Medicinova (MNOV) Gross Margin (2025)
Medicinova's (MNOV) quarterly Gross Margin came in at 3.13% in Q4 2025, down 51.99% on a QoQ basis from 6.53% in Q3 2025.
Medicinova (MNOV) Gross Margin (2025) Analysis & Trends
Medicinova (MNOV) has 1 years of Gross Margin data on file, last reported at 3.13% in Q4 2025.
- On a quarterly basis, Gross Margin changed N/A year-over-year to 3.13% in Q4 2025; TTM through Dec 2025 was 7.58%, a N/A change from a year earlier, with the FY2025 full-year figure at 7.58%, changed N/A from the prior year.
- Gross Margin for Q4 2025 stood at 3.13%, down from 6.53% in the prior quarter.
- Over the last five years, Gross Margin for MNOV reached as high as 13.56% in Q2 2025 and fell as low as 3.13% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | 3.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.13% |
| Sep 30, 2025 | 6.53% |
| Jun 30, 2025 | 13.56% |